GE HealthCare Technologies/$GEHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GE HealthCare Technologies
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ticker
$GEHC
Sector
Primary listing
Employees
54,000
Headquarters
Website
GEHC Metrics
BasicAdvanced
$29bn
15.51
$4.17
0.87
$0.14
0.22%
Price and volume
Market cap
$29bn
Beta
0.87
52-week high
$89.77
52-week low
$58.75
Average daily volume
6.2m
Dividend rate
$0.14
Financial strength
Current ratio
1.222
Quick ratio
0.81
Long term debt to equity
95.779
Total debt to equity
97.055
Dividend payout ratio (TTM)
3.35%
Interest coverage (TTM)
7.83%
Profitability
EBITDA (TTM)
3,600
Gross margin (TTM)
39.14%
Net profit margin (TTM)
9.10%
Operating margin (TTM)
13.95%
Effective tax rate (TTM)
23.40%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
5.31%
Return on equity (TTM)
19.46%
Valuation
Price to earnings (TTM)
15.508
Price to revenue (TTM)
1.405
Price to book
2.76
Price to tangible book (TTM)
-4.67
Price to free cash flow (TTM)
19.403
Free cash flow yield (TTM)
5.15%
Free cash flow per share (TTM)
3.333
Dividend yield (TTM)
0.22%
Forward dividend yield
0.22%
Growth
Revenue change (TTM)
5.96%
Earnings per share change (TTM)
-12.39%
3-year revenue growth (CAGR)
3.90%
3-year earnings per share growth (CAGR)
3.45%
3-year dividend per share growth (CAGR)
67.11%
What the Analysts think about GEHC
Analyst ratings (Buy, Hold, Sell) for GE HealthCare Technologies stock.
GEHC Financial Performance
Revenues and expenses
GEHC Earnings Performance
Company profitability
GEHC News
AllArticlesVideos
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
Business Wire·3 days ago
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
Business Wire·6 days ago
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs